DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS

Increased intrathecal synthesis and oligoclonal banding of immunoglobulins (Ig) in cerebrospinal fluid (CSF) are major immunological findings in multiple sclerosis. Free light chains are fragments of Ig molecules that are produced in parallel to oligoclonal Ig, and their production reflects total Ig...

Full description

Bibliographic Details
Main Authors:	V. D. Nazarov, S. V. Lapin, E. A. Surkova, E. P. Evdoshenko, G. S. Makshakov, Areg A. Totolian
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2015-06-01
Series:	Медицинская иммунология
Subjects:	multiple sclerosis free light chains clinically isolated syndrome oligoclonal bands cerebrospinal fluid
Online Access:	https://www.mimmun.ru/mimmun/article/view/888

Similar Items

Diagnostic significance of intrathecally synthesized immunoglobulins against neurotropic viruses (MRZ-reaction) in diagnosis of multiple sclerosis
by: A. N. Moshnikova, et al.
Published: (2020-02-01)

"AN ESTIMATION OF OLIGOCLONAL BANDS IN PATIENTS WITH MULTIPLE SCLEROSIS"
by: M. H. Harirchian, et al.
Published: (2004-09-01)

"AN ESTIMATION OF OLIGOCLONAL BANDS IN PATIENTS WITH MULTIPLE SCLEROSIS"
by: M. H. Harirchian, et al.
Published: (2004-08-01)

Oligoclonal bands as predictors of multiple sclerosis in clinically isolated syndrome
by: Klaudia Sapko, et al.
Published: (2018-07-01)

Oligoclonal bands as predictors of multiple sclerosis in clinically isolated syndrome
by: Klaudia Sapko, et al.
Published: (2018-07-01)

Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis
by: Maria-Eleftheria Evangelopoulos, et al.
Published: (2022-11-01)

Multiple sclerosis in Brazil: analysis of cerebrospinal fluid by standard methods
by: MARZIA PUCCIONI-SOHLER, et al.
Published: (1999-12-01)

Single-cell transcriptomics combined with proteomics of intrathecal IgG reveal transcriptional heterogeneity of oligoclonal IgG-secreting cells in multiple sclerosis
by: Justyna Polak, et al.
Published: (2023-06-01)

The Role of Antibodies in the Pathogenesis of Multiple Sclerosis
by: Xiaoli Yu, et al.
Published: (2020-10-01)

Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG
by: David Zeman, et al.
Published: (2015-03-01)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
by: Ranjani Ganapathy Subramanian, et al.
Published: (2021-11-01)

Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features
by: Xiang Zhang, et al.
Published: (2023-11-01)

Molecular biomarkers in multiple sclerosis
by: Tjalf Ziemssen, et al.
Published: (2019-12-01)

Oligoclonal Band Straightening Based on Optimized Hierarchical Warping for Multiple Sclerosis Diagnosis
by: Farah Haddad, et al.
Published: (2022-01-01)

The Effect of Oligoclonal Bands in Patients with Multiple Sclerosis
by: Nurhan Kaya Tutar, et al.
Published: (2022-12-01)

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
by: Diana Ferraro, et al.
Published: (2020-10-01)

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
by: Evangelos Katsarogiannis, et al.
Published: (2023-07-01)

Cerebrospinal Fluid Analysis in Multiple Sclerosis Diagnosis: An Update
by: Bruna Lo Sasso, et al.
Published: (2019-06-01)

The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01)

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
by: Benjamin Vlad, et al.
Published: (2023-03-01)

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
by: Clàudia Coll‐Martinez, et al.
Published: (2021-12-01)

The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis
by: Lorenzo Gaetani, et al.
Published: (2023-12-01)

Brain MRI in patients with multiple sclerosis with oligoclonal cerebrospinal fluid bands
by: Mesaroš Šarlota, et al.
Published: (2003-01-01)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
by: Enric Monreal, et al.
Published: (2023-10-01)

Baló’s concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures
by: S. Jarius, et al.
Published: (2018-01-01)

Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement
by: Mariola Świderek-Matysiak, et al.
Published: (2023-02-01)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
by: Benjamin Vlad, et al.
Published: (2023-09-01)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
by: Makbule Senel, et al.
Published: (2019-03-01)

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
by: Franz Felix Konen, et al.
Published: (2022-07-01)

MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study
by: Aurora Zanghì, et al.
Published: (2023-08-01)

Decreased Intrathecal Concentrations of Free Light Chains Kappa in Multiple Sclerosis Patients Taking Very High Effective Disease-Modifying Treatment
by: Marie Süße, et al.
Published: (2022-03-01)

An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands
by: Fotini Boufidou, et al.
Published: (2023-01-01)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
by: Veronika Klose, et al.
Published: (2023-05-01)

Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
by: Gleb Makshakov, et al.
Published: (2015-01-01)

Investigation of Oligoclonal IgG Bands in Tear Fluid of Multiple Sclerosis Patients
by: Martin W. Hümmert, et al.
Published: (2019-05-01)

Vitamin D deficiency in relation with the systemic and central inflammation during multiple sclerosis
by: Feki Sawsan, et al.
Published: (2023-01-01)

Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and Prognosis
by: Mattia Fonderico, et al.
Published: (2021-10-01)

Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study
by: Charlotte Baumgaertel, et al.
Published: (2019-07-01)

IgG intrathecal synthesis and specific antibody index in patients with neurocysticercosis
by: Luís R. Machado, et al.
Published: (2002-06-01)

The importance of follow-up and re-diagnosis of patients with demyelinating syndrome suspicion - a case study of a conversion from radiologically isolated syndrome to clinically definite multiple sclerosis
by: Marcin Kulczyński, et al.
Published: (2020-07-01)